These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31518871)

  • 1. Synthesis and in vitro antitumor activity evaluation of copper(II) complexes with 5-pyridin-2-yl-[1,3]dioxolo[4,5-g]isoquinoline derivatives.
    Zhang YL; Deng CX; Zhou WF; Zhou LY; Cao QQ; Shen WY; Liang H; Chen ZF
    J Inorg Biochem; 2019 Dec; 201():110820. PubMed ID: 31518871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper(II/I) complexes of 5-pyridin-2-yl-[1,3]dioxolo[4,5-g]isoquinoline: synthesis, crystal structure, antitumor activity and DNA interaction.
    Huang KB; Chen ZF; Liu YC; Wang M; Wei JH; Xie XL; Zhang JL; Hu K; Liang H
    Eur J Med Chem; 2013; 70():640-8. PubMed ID: 24211640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, crystal structure and biological evaluation of a new dasatinib copper(II) complex as telomerase inhibitor.
    Qin QP; Meng T; Tan MX; Liu YC; Luo XJ; Zou BQ; Liang H
    Eur J Med Chem; 2018 Jan; 143():1597-1603. PubMed ID: 29133054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
    Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
    J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses, Crystal Structures, and Antitumor Activities of Copper(II) and Nickel(II) Complexes with 2-((2-(Pyridin-2-yl)hydrazono)methyl)quinolin-8-ol.
    Yang QY; Cao QQ; Qin QP; Deng CX; Liang H; Chen ZF
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29949884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-activating nuclease and anticancer activities of copper(II) complexes with aryl-modified 2,6-di(thiazol-2-yl)pyridine.
    Li L; Du K; Wang Y; Jia H; Hou X; Chao H; Ji L
    Dalton Trans; 2013 Aug; 42(32):11576-88. PubMed ID: 23843095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Bromo-oxoisoaporphine platinum(II) complexes exhibit tumor cell cytotoxcicity via inhibition of telomerase activity and disruption of c-myc G-quadruplex DNA and mitochondrial functions.
    Wei ZZ; Qin QP; Meng T; Deng CX; Liang H; Chen ZF
    Eur J Med Chem; 2018 Feb; 145():360-369. PubMed ID: 29335202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity.
    Dam J; Ismail Z; Kurebwa T; Gangat N; Harmse L; Marques HM; Lemmerer A; Bode ML; de Koning CB
    Eur J Med Chem; 2017 Jan; 126():353-368. PubMed ID: 27907874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities.
    Kordestani N; Amiri Rudbari H; Fernandes AR; Raposo LR; Luz A; Baptista PV; Bruno G; Scopelliti R; Fateminia Z; Micale N; Tumanov N; Wouters J; Abbasi Kajani A; Bordbar AK
    Dalton Trans; 2021 Mar; 50(11):3990-4007. PubMed ID: 33650599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structurally related hydrazone-based metal complexes with different antitumor activities variably induce apoptotic cell death.
    Megger DA; Rosowski K; Radunsky C; Kösters J; Sitek B; Müller J
    Dalton Trans; 2017 Apr; 46(14):4759-4767. PubMed ID: 28338141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
    Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
    Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemodynamic therapy agents Cu(II) complexes of quinoline derivatives induced ER stress and mitochondria-mediated apoptosis in SK-OV-3 cells.
    Shen WY; Jia CP; Mo AN; Liang H; Chen ZF
    Eur J Med Chem; 2021 Nov; 223():113636. PubMed ID: 34175540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of 4-([2,2':6',2″-terpyridin]-4'-yl)-N,N-diethylaniline Ni(II) and Pt(II) complexes and exploration of their in vitro cytotoxic activities.
    Zou HH; Wang L; Long ZX; Qin QP; Song ZK; Xie T; Zhang SH; Liu YC; Lin B; Chen ZF
    Eur J Med Chem; 2016 Jan; 108():1-12. PubMed ID: 26619388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitumor activity of copper(II) complexes of imidazole derivatives.
    Li X; Chen K; Lai J; Wang S; Chen Y; Mo X; Chen Z
    J Inorg Biochem; 2024 Nov; 260():112690. PubMed ID: 39126756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, DNA interaction and anticancer activity of copper(II) complexes with 4'-phenyl-2,2':6',2″-terpyridine derivatives.
    Liang JW; Wang Y; Du KJ; Li GY; Guan RL; Ji LN; Chao H
    J Inorg Biochem; 2014 Dec; 141():17-27. PubMed ID: 25172994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordination geometry-induced optical imaging of l-cysteine in cancer cells using imidazopyridine-based copper(ii) complexes.
    Priyanga S; Khamrang T; Velusamy M; Karthi S; Ashokkumar B; Mayilmurugan R
    Dalton Trans; 2019 Jan; 48(4):1489-1503. PubMed ID: 30632585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antitumor activity of novel benzimidazole-based Cu(II) complexes.
    Hu J; Guo Y; Zhao J; Zhang J
    Bioorg Med Chem; 2017 Oct; 25(20):5733-5742. PubMed ID: 28917448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties.
    Choroba K; Machura B; Szlapa-Kula A; Malecki JG; Raposo L; Roma-Rodrigues C; Cordeiro S; Baptista PV; Fernandes AR
    Eur J Med Chem; 2021 Jun; 218():113404. PubMed ID: 33823390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands.
    Deng J; Yu P; Zhang Z; Wang J; Cai J; Wu N; Sun H; Liang H; Yang F
    Eur J Med Chem; 2018 Oct; 158():442-452. PubMed ID: 30241011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of DNA/Protein interactions and cytotoxic studies of copper(II) complexes incorporated with N, N donor ligands and terpyridine ligand.
    Tummalapalli K; C S V; Munusami P; Pathak M; M M B
    Int J Biol Macromol; 2017 Feb; 95():1254-1266. PubMed ID: 27838416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.